慢性抗凝治疗与无菌性翻修全髋关节置换术后并发症风险增加相关
利用大型全国数据库回顾性识别2014至2019年间9,421例无菌性翻修全髋关节置换术患者,其中1,790例(19.0%)为慢性抗凝组,7,631例(81.0%)为非抗凝组。慢性抗凝组90天假体周围感染、手术部位感染和机械性假体并发症的比值比升高,2年假体周围感染和机械性假体并发症的比值比亦升高,2年内再手术风险增加。作者建议在多学科环境下对慢性抗凝患者进行风险-获益比咨询。
要点
- 慢性抗凝组90天假体周围感染OR 3.2、手术部位感染OR 3.6、机械性假体并发症OR 3.5,均P < .001。
- 慢性抗凝组2年假体周围感染OR 3.3、机械性假体并发症OR 3.2,均P < .001。
- 慢性抗凝组初始无菌性翻修全髋关节置换术后2年内再手术OR 1.9,P < .001。
核心结论
- 慢性抗凝患者无菌性翻修全髋关节置换术后90天和2年并发症的比值比显著更高,包括假体周围感染、手术部位感染和机械性假体并发症。
- 作者认为,接受慢性抗凝治疗并 undergoing 翻修全髋关节置换术的患者应在多学科环境下就其慢性抗凝状态的风险-获益比进行咨询,以优化术后结局。
研究设计与样本
- 利用大型全国数据库回顾性识别2014年至2019年间接受无菌性翻修全髋关节置换术的9,421例患者。
- 患者分为两组:慢性抗凝组1,790例(19.0%),定义为翻修全髋关节置换术前6个月内及术后有抗凝处方配药记录;非慢性抗凝组7,631例(81.0%)。
- 采用单因素和多因素分析比较两组90天和2年术后并发症,多因素分析控制性别、年龄和合并症。
主要发现
- 90天时,慢性抗凝组假体周围感染比值比升高(OR 3.2,P < .001),手术部位感染比值比升高(OR 3.6,P < .001),机械性假体并发症比值比升高(OR 3.5,P < .001),机械性假体并发症包括任何无菌性松动、假体脱位或假体破损。
- 2年时,慢性抗凝组假体周围感染比值比升高(OR 3.3,P < .001),机械性假体并发症比值比升高(OR 3.2,P < .001)。
- 慢性抗凝组初始无菌性翻修全髋关节置换术后2年内再手术风险升高(OR 1.9,P < .001)。
临床怎么用
- 作者认为,接受慢性抗凝治疗并接受翻修全髋关节置换术的患者应在多学科环境下就其慢性抗凝状态的风险-获益比进行咨询,以优化术后结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With an aging global population, the incidence of revision total hip arthroplasty (rTHA) is expected to increase markedly. While patients undergoing primary total hip arthroplasty who require chronic anticoagulation (AC) have been associated with increased postoperative complications, less is known about the impact of chronic AC status on postoperative complications in the rTHA setting. This study sought to compare complication rates following aseptic rTHA between patients who were on chronic AC and those who were not. METHODS: A large national database was utilized to retrospectively identify 9,421 patients who underwent aseptic rTHA between 2014 and 2019. Patients were divided into 2 cohorts: 1,790 patients (19.0%) were in the chronic AC cohort (ie, having an AC prescription filled within 6 months prior to and following rTHA), and 7,631 patients (81.0%) were not on chronic AC. Postoperative complications at 90-days and 2-years were compared between cohorts utilizing univariate and multivariate analyses, controlling for sex, age, and comorbidities. RESULTS: At 90-days, chronic AC patients had increased odds of prosthetic joint infections (PJIs) (odds ratio [OR] 3.2, P < .001), surgical site infections (OR 3.6, P < .001), and mechanical prosthetic complications (OR 3.5, P < .001), which included any aseptic loosening, implant dislocation, or broken prosthetic. At 2-years, chronic AC patients had increased odds of PJI (OR 3.3, P < .001) as well as mechanical prosthetic complications (OR 3.2, P < .001). Chronic AC patients were also at increased risk for reoperation within 2 years after initial aseptic rTHA (OR 1.9, P < .001). CONCLUSIONS: Patients on chronic AC have significantly higher odds of 90-day and 2-year complications after aseptic rTHA. This includes increased odds of PJI, surgical site infection, and mechanical prosthetic complications. Patients receiving chronic AC who undergo rTHA should be counseled on the risk-benefit ratio of their chronic AC status in a multidisciplinary setting to optimize their postoperative outcomes.
引用
- Heo KY, Goel RK, Fuqua A, et al. Chronic Anticoagulation is Associated With Increased Risk for Postoperative Complications Following Aseptic Revision Total Hip Arthroplasty. J Arthroplasty. 2024. PMID: 38237877. doi:10.1016/j.arth.2024.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。